Home LiteratureArticle Details
PMID: 2892132 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Infection with human T-cell leukemia virus type I in patients with leukemia.

The New England journal of medicine ·Vol. 318 ·No. 4 ·1988-01-28 ·Pages 219-22

Minamoto GY, Gold JW, Scheinberg DA, Hardy WD, Chein N, Zuckerman E, Reich L, Dietz K, Gee T, Hoffer J

Abstract

Among 211 adults with leukemia who received multiple transfusions, 6 were found to be seropositive for human T-cell leukemia virus Type I (HTLV-I). Before the positive serum specimens were obtained, these patients received a mean of 14 units of red cells and 78 units of platelets. Seroconversion could be documented in three patients. None of the 6 patients seropositive for HTLV-I had a T-cell leukemia, other illnesses attributable to HTLV-I infection, or risk factors for HTLV-I infection other than transfusion: none were seropositive for human immunodeficiency virus. Patients with leukemia who receive multiple transfusions appear to be at risk for HTLV-I infection.

MeSH Terms
Antibodies, Viral/analysis Deltaretrovirus Antibodies Deltaretrovirus Infections/etiology Female Humans Leukemia/complications Male Risk Factors Transfusion Reaction
Chemicals
Antibodies, Viral Deltaretrovirus Antibodies
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Minamoto G Y
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Gold J W
Scheinberg D A
Hardy W D
Chein N
Zuckerman E
Reich L
Dietz K
Gee T
Hoffer J
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1988-01-28
Pages
219-22
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com